MX2019006941A - Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. - Google Patents
Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor.Info
- Publication number
- MX2019006941A MX2019006941A MX2019006941A MX2019006941A MX2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A MX 2019006941 A MX2019006941 A MX 2019006941A
- Authority
- MX
- Mexico
- Prior art keywords
- alleviating
- preventing
- carbamate compound
- tremor syndrome
- tremors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se relaciona a un uso de una composición farmacéutica que incluye un compuesto de carbamato de la fórmula química 1 y se administra para prevenir, aliviar o tratar temblores o el síndrome de temblor.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160170225 | 2016-12-14 | ||
PCT/KR2017/014743 WO2018111009A1 (ko) | 2016-12-14 | 2017-12-14 | 진전 또는 진전 증후군의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019006941A true MX2019006941A (es) | 2019-09-06 |
Family
ID=62558966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019006941A MX2019006941A (es) | 2016-12-14 | 2017-12-14 | Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. |
Country Status (13)
Country | Link |
---|---|
US (1) | US11033531B2 (es) |
EP (1) | EP3556364A4 (es) |
JP (1) | JP7086076B2 (es) |
KR (1) | KR102635941B1 (es) |
CN (1) | CN110267657B (es) |
AU (1) | AU2017374459B2 (es) |
BR (1) | BR112019012000A2 (es) |
CA (1) | CA3046300A1 (es) |
CL (1) | CL2019001623A1 (es) |
IL (1) | IL267191B2 (es) |
MX (1) | MX2019006941A (es) |
WO (1) | WO2018111009A1 (es) |
ZA (1) | ZA201903749B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2973111T3 (es) * | 2017-11-14 | 2024-06-18 | Sk Biopharmaceuticals Co Ltd | Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio |
MX2021003203A (es) * | 2018-09-21 | 2021-05-27 | Sk Biopharmaceuticals Co Ltd | Compuesto de carbamato y uso de la formulacion que comprende el mismo en prevenir, aliviar, o tratar trastorno de estres agudo o trastorno de estres post-traumatico. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ551954A (en) | 2001-02-27 | 2008-07-31 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating movement disorders |
WO2005097136A1 (en) | 2004-03-29 | 2005-10-20 | Merck & Co., Inc. | Biaryl substituted pyrazinones as sodium channel blockers |
US7598279B2 (en) * | 2005-04-22 | 2009-10-06 | Sk Holdings Co., Ltd. | Neurotherapeutic azole compounds |
US8633229B2 (en) * | 2007-03-05 | 2014-01-21 | Indus Biotech Pvt. Ltd. | Pharmaceutical composition having dopaminergic activity |
BRPI0924997B1 (pt) | 2009-06-22 | 2024-01-16 | Sk Biopharmaceuticals Co., Ltd | Método para preparar um composto de éster do ácido 1-aril-2- tetrazoil etil carbâmico |
US8404461B2 (en) * | 2009-10-15 | 2013-03-26 | SK Biopharmaceutical Co. Ltd. | Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester |
CN109939092B (zh) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
KR102489052B1 (ko) * | 2016-05-19 | 2023-01-16 | 에스케이바이오팜 주식회사 | 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도 |
-
2017
- 2017-12-14 WO PCT/KR2017/014743 patent/WO2018111009A1/ko unknown
- 2017-12-14 EP EP17880232.8A patent/EP3556364A4/en active Pending
- 2017-12-14 CA CA3046300A patent/CA3046300A1/en active Pending
- 2017-12-14 US US16/468,936 patent/US11033531B2/en active Active
- 2017-12-14 AU AU2017374459A patent/AU2017374459B2/en active Active
- 2017-12-14 JP JP2019531817A patent/JP7086076B2/ja active Active
- 2017-12-14 CN CN201780077642.3A patent/CN110267657B/zh active Active
- 2017-12-14 KR KR1020197018409A patent/KR102635941B1/ko active IP Right Grant
- 2017-12-14 MX MX2019006941A patent/MX2019006941A/es unknown
- 2017-12-14 BR BR112019012000-9A patent/BR112019012000A2/pt active Search and Examination
-
2019
- 2019-06-10 IL IL267191A patent/IL267191B2/en unknown
- 2019-06-11 ZA ZA2019/03749A patent/ZA201903749B/en unknown
- 2019-06-12 CL CL2019001623A patent/CL2019001623A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP7086076B2 (ja) | 2022-06-17 |
EP3556364A4 (en) | 2020-06-17 |
CN110267657A (zh) | 2019-09-20 |
KR20190087573A (ko) | 2019-07-24 |
AU2017374459B2 (en) | 2023-04-27 |
RU2019121914A3 (es) | 2021-04-21 |
WO2018111009A1 (ko) | 2018-06-21 |
JP2020502137A (ja) | 2020-01-23 |
IL267191B2 (en) | 2023-05-01 |
IL267191B1 (en) | 2023-01-01 |
ZA201903749B (en) | 2022-01-26 |
AU2017374459A1 (en) | 2019-07-04 |
US20190336481A1 (en) | 2019-11-07 |
CN110267657B (zh) | 2022-12-13 |
CL2019001623A1 (es) | 2019-08-23 |
IL267191A (es) | 2019-07-31 |
BR112019012000A2 (pt) | 2019-10-29 |
RU2019121914A (ru) | 2021-01-15 |
KR102635941B1 (ko) | 2024-02-13 |
US11033531B2 (en) | 2021-06-15 |
CA3046300A1 (en) | 2018-06-21 |
EP3556364A1 (en) | 2019-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017003658A2 (pt) | composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica. | |
MX2022012313A (es) | Oxisteroles y metodos de uso de los mismos. | |
WO2017204445A3 (ko) | Alk 단백질의 분해를 유도하는 약학적 조성물 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 | |
NZ729005A (en) | Aminopyrimidinyl compounds as jak inhibitors | |
PH12017500416A1 (en) | Compounds and compositions as raf kinase inhibitors | |
PH12019501690A1 (en) | Pyrimidine compound and pharmaceutical use thereof | |
MY196186A (en) | Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor | |
MX2018005041A (es) | Compuestos para tratar la esclerosis lateral amiotrofica. | |
PH12019500196A1 (en) | Compounds and compositions and uses thereof | |
NZ730250A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
MX2018014080A (es) | Uso de compuesto de carbamato para prevenir o tratar fibromialgia o sindrome funcional asociado con fibromialgia. | |
MX2019006863A (es) | Inhibidores de heparanasa y uso de los mismos. | |
MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
PH12019500198A1 (en) | Compounds and compositions and uses thereof | |
SG10201907289VA (en) | Monomethylfumarate prodrug compositions | |
PH12020550252A1 (en) | Novel phenylpyridine derivative and pharmaceutical composition comprising the same | |
MX2019006940A (es) | Uso de compuestos de carbamato para prevencion, alivio o tratamiento del trastorno bipolar. | |
MX2019006941A (es) | Uso de compuesto de carbamato para prevenir, aliviar o tratar temblores o el sindrome de temblor. | |
MX2018016339A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. | |
MX2018014081A (es) | Uso de compuesto de carbamato para prevenir o tratar neuralgia trigeminal. | |
MX2016008968A (es) | Compuestos organicos. | |
MX2018003565A (es) | Derivados de 2,3,4,5-tetrahidropiridin-6-amina. | |
EA033297B1 (ru) | Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы | |
PH12017501560A1 (en) | Tetrahydropyranyl benzamide derivatives | |
MX2021004342A (es) | Uso de compuesto de carbamato para prevenir, aliviar o tratar neuropatía periférica diabética o neuropatía periférica inducida por quimioterapia. |